Advertisement
week in cancer news
  • April 4: The Week in Cancer News

    Some early-stage breast cancer patients may not need surgery, and FDA approves Imfinzi for muscle-invasive bladder cancer.

    by Eric Fitzsimmons

  • March 28: The Week in Cancer News

    New prostate cancer surgery approach can prevent sexual side effects, and some people with esophageal cancer may be able to avoid surgery.

    by Thomas Celona

  • March 21: The Week in Cancer News

    Cooling and compression help manage common side effect of chemotherapy, and deadlines encourage people to complete colorectal cancer screening.

    by Marci A. Landsmann

  • March 14: The Week in Cancer News

    Pickleball encourages more activity in cancer survivors, and urine test detects aggressive prostate cancer.

    by Kevin McLaughlin

  • March 7: The Week in Cancer News

    HPV vaccine credited for 80% drop in lesions that can lead to cervical cancer, and FDA approves targeted therapy for esophageal cancer.

    by Thomas Celona

  • February 28: The Week in Cancer News

    Exercise associated with increased survival after colon cancer, and screening costs remain a hurdle for women with dense breasts.

    by Eric Fitzsimmons

  • February 21: The Week in Cancer News

    Men with metastatic prostate cancer urged to ask questions about care, and early-phase study suggests benefit of pancreatic cancer vaccine.

    by Marci A. Landsmann

  • February 14: The Week in Cancer News

    Pesticide firms try to block cancer-related lawsuits, and cancer pain leads to greater tobacco and cannabis use.

    by Kevin McLaughlin

  • February 7: The Week in Cancer News

    Researchers explore musical toxicity from cancer treatment, and kidney cancer vaccine shows potential in early trial.

    by Eric Fitzsimmons

  • January 31: The Week in Cancer News

    FDA approves an antibody-drug conjugate for people with HER2-ultralow breast cancer, and historic redlining practices have a lingering impact on cancer outcomes.

    by Thomas Celona